Trials / Completed
CompletedNCT04583475
Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 163 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study whose main objective is to estimate the frequency of patients benefiting from an intensification of AOM treatment at 3 months.
Conditions
Timeline
- Start date
- 2021-02-25
- Primary completion
- 2023-06-22
- Completion
- 2023-06-22
- First posted
- 2020-10-12
- Last updated
- 2025-12-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04583475. Inclusion in this directory is not an endorsement.